Physician profile
Jesse Dashe
NPI 1487917423
$10,424.98
in general payments reported to CMS, 2019-2025
15 companies · $255 in 2025
The $255 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,602 · 2020: $998 · 2021: $1,079 · 2022: $3,573 · 2023: $1,755 · 2024: $162 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,264 · Food and Beverage: $908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,264.48 |
| Food and Beverage | $907.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,881.19 | 2022-2023 | |
| Sequoia Surgical, INC. | $1,862.09 | 2019-2022 | |
| Trimed, INC. | $1,127.04 | 2021-2025 | |
| Acumed LLC | $1,088.58 | 2019 | |
| Evolution Surgical, INC | $983.54 | 2023-2024 | |
| Skeletal Dynamics INC | $482.75 | 2019-2024 | Ijs, Geminus, Implate |
| Endo Pharmaceuticals INC. | $395.57 | 2019-2022 | |
| Axogen | $203.61 | 2022-2025 | |
| Integra Lifesciences Corporation | $150.71 | 2019 | |
| Depuy Synthes Sales INC. | $109.75 | 2021 | |
| Stryker Corporation | $49.17 | 2024 | Variax |
| Smith+Nephew, INC. | $40.20 | 2023 | Hat-Trick |
| Trice Medical, INC. | $19.79 | 2022 | |
| Orthofix Medical, INC. | $19.68 | 2023 | Physio-Stim |
| Sonex Health, INC. | $11.31 | 2025 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Dashe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.